Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase
ModernaTX, Inc.
Hana M El Sahly; Lindsey R Baden; Brandon Essink; Susanne Doblecki-Lewis; Judith M Martin; Evan J Anderson; Thomas B Campbell; Jesse Clark; Lisa A Jackson; Carl J Fichtenbaum; Marcus Zervos; Bruce Rankin; Frank Eder; Gregory Feldman; Christina Kennelly; Laurie Han-Conrad; Michael Levin; Kathleen M Neuzil; Lawrence Corey; Peter Gilbert; Holly Janes; Dean Follmann; Mary Marovich; Laura Polakowski; John R Mascola; Julie E Ledgerwood; Barney S Graham; Allison August; Heather Clouting; Weiping Deng; Shu Han; Brett Leav; Deb Manzo; Rolando Pajon; Florian Schödel; Joanne E Tomassini; Honghong Zhou; Jacqueline Miller; COVE Study Group